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SUMMARY 
 Retinoblastoma (Rb) is a malignant retinal tumor on young children which is often founded before the age 
of 5. This cancer disease appears when both of RB1 alleles on 13q14.2 chromosome are mutated. The aim of 
this research is to evaluate the ability of Multiplex Ligation-dependent Probe Amplification (MLPA) in 
screening of RB1 gene insertion/deletions in Vietnamese patients with Rb. Genomic DNA was isolated from 
peripheral blood of the research subjects and subsequently analyzed by MLPA technique. To prove the results 
of MLPA, quantitative real-time PCR was used for determining the RB1 gene copy number for all samples. 
Two significant deletion mutations were identified on two different Rb patients, one is the deletion from exon 4 
to exon 27 recorded on KVM38 sample, and the other is the complete removal of an allele on KVM21 sample. 
The MLPA showed a complete correlation with real-time PCR results. These are the disease causing 
mutations, can be inherited and they are important evidences for genetic counseling and clinical management. 
Those results have proven the high speed and reliability of MLPA method in identifying deletion/duplication 
mutations on Rb patients. 
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INTRODUCTION 
 Retinoblastoma (Rb) is a malignant retinal tumor 
caused by mutations in both alleles of the RB1 gene 
and often encountered in young children under 5 
years old. This tumor appears on both sexes with the 
ratio ranging from 1/15000 to 1/20000 regardless the 
races (Kivelä, 2009;Vogel, 1979). Approximately 
40% of patients are heritable, and 60% cases are 
non-heritable Rb (Gao, et al., 2011). Both types of 
Rb are caused by the inactivation of both alleles of 
tumor suppressing genes RB1 which are located on 
chromosome 13 (Dimaras, et al., 2012). Heritable 
form of Rb is caused by first germinal mutation and 
the second one acquired in the somatic retina cells. 
RB1 protein plays an important role in regulating 
cell proliferation and differentiation, it involves in 
G1/S transition by inhibiting E2F transcription 
factors which are necessary to active S phase. The 
inactivation of RB1 has the most significant impact 
on a group of cone cell precursors in the 
development of retina. The high expression of RB1 
gene in these cell groups proves its important role in 
the regulation of cell proliferation (Xu et al., 2009). 
Mutations in the RB1 gene are highly heterogeneous 
and scattered in the promoter and the 27 exons. To 
date, more than 1600 distinct mutations, ranging 
from small mutations to large deletions, have been 
registered in the RB1 Gene Mutation Database (He 
et al., 2014). Every year, Vietnam National Institute 
of Ophthalmology diagnosed about 40 new cases of 
Rb. Most of the cases, patients were hospitalized in 
the late stage and missed the chance of saving their 
eyes. Among those cases, the majority of patients 
were born in a family with Retinoblastoma 
anamnesis which indicated a tight relationship 
between heredity and this disease. In 2005, Nguyen 
Cong Kiet and Nguyen Tri Dung had studied about 
inherited characteristic of 30 RB1 cases in Viet Nam. 
Using karyotyping method, this research group had 
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identified only one case that had a deletion on 13q14 
chromosome (Cong Kiet N, Dung Tri N, 2005). In 
2014, Nguyen  Hai  Ha and colleagues had identified 
two mutations in RB1 gene of 2 children with Rb 
(Hai Ha N et al., 2014). In 2016, Nguyen Hai Ha and 
colleagues had combined DNA and cDNA analysis 
in screening of RB1 gene mutation of a family with 
Rb. The result has shown that the healthy father and 
his two affected children carried a mutation resulting 
in aberrant RB1 pre-mRNA splicing. In the 
developed countries, RB1 gene testing has become a 
periodic test on Rb patients (Robson et al., 2015), 
due to RB1 mutation is a source of evidences for 
genetic counseling and clinical management. In 
Vietnam, although a high amount of budget has been 
invested for the development of clinical treatment 
technique, the development of molecular technique 
for early diagnose of Rb is almost still left open. 
 About 15%–25% of mutations detected in Rb 
cases were large deletion/duplication on RB1 gene 
(Ahani et al., 2011). Due to the limitation of Sanger 
sequencing that allows only the detection of 
missense mutation, small deletion/duplication, 
combining multiple technique to identify large 
deletion/duplication on RB1 gene is necessary. From 
2002, Multiplex Ligation dependent Probe 
Amplification (MLPA) had been accepted as 
sufficiently sensitive technique for detecting copy 
number (gain or loss) of a single exon of human  
gene (Schouten, et al., 2002). This is a high 
throughput method developed to identify copy 
number of up to 50 DNA sequences using a 
multiplex PCR reaction. To date, the information of 
MLPA application in genetic testing for RB1 in 
Vietnam is still unknown. The present study aims to 
evaluate MLPA for detecting deletion/duplication 
mutations in molecular diagnosis of Rb. From here, 
it is more possible to avoid deficiencies in diagnosis 
and the data for genetic counseling for the patient’s 
family will be more complete. 
MATERIALS AND METHODS 
Study subjects 
 This study selected DNA samples from 4 
children, one is a healthy child (REF) and three 
children (KVM21, KVM22 and KVM23) diagnosed 
with Rb by ophthalmologists from the Vietnam 
National Institute of Ophthalmology, Hanoi, 
Vietnam (Table 1). All of these samples were 
negative with RB1 gene point mutations screening by 
direct sequencing method. The research has been 
conducted at the Institute of Genome Research, 
Vietnam Academy of Science and Technology. 
 
Table 1. Summary of patient’s disease status 
Sample’s ID Sex 
Tumor location 
Family anamnesis 
Left eye Right eye 
REF  Female No No No 
KVM21 Male Yes Yes Affected Father  
KVM22 Female Yes Yes No 
KVM38 Female Yes Yes No 
 
Genomic DNA isolation 
 Peripheral blood from patients and healthy 
people were stored in EDTA tubes in –20oC fridge 
until use. We used E.Z.N.A Blood DNA mini kit 
(Promega) to extract genomic DNA from peripheral 
blood samples according to the manufacturer’s 
protocol. After purification, genomic DNA samples 
were quantified by Qubit Fluorometer BR DNA kit 
(Broad-range). Fluorescent signal from the dye is 
proportional with concentration of bound DNA. 
From here, qubit fluorometer will receive the signal 
and calculate double stranded DNA concentration 
based on the standard curve built from standard 
samples (included in the kit). 
Multiplex ligation-dependent probe amplification 
(MLPA) assay 
 To identify deletions/duplications on RB1 
gene, MPLA technique was performed using 
SALSA MLPA P047-D1 RB1 Probemix kit 
(MRC-Holland, Amsterdam, Netherlands) 
following the manufacturer’s protocol. P047-D1 
RB1 probemix contain the probes for 26 over 27 
RB1’s exons. There is not any probe for exon 15 
since it is located very close to the adjacent exons. 
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Furthermore, this probemix contains several 
probes for RB1 gene’s junctions (48 kb upstream 
and 35 kb downstream of the gene) as well as one 
probe for DLEU1 gene and two probes for PCDH8 
gene at the rear of RB1 gene which are located 1.6 
Mb and 4.5 Mb, respectively. To prepare for 
MLPA reaction, total DNA was diluted to the 
concentration of 10ng/µl in TE 0.1. Fifty ng of 
genomic DNA with a total volume of 5µl was 
denatured and hybridized with SALSA probemix, 
following by incubation at 60oC for 16–20h. 
Subsequently, the annealed probes were ligated 
using Ligase65 at 54oC for 5min. In the next step, 
all ligated products were used as template for 
DNA amplification. The amplicons were run on 
Genetic Analyzer 3500 (Applied Biosystems, 
Foster City, CA). The collected data was analyzed 
by Coffalyzer.net software. Subject having normal 
copy number was expected to produce a 
normalized signal value ratio of 0.8–1.2, 0.65 and 
1.3 were used as cut-off values for heterozygous 
deletion and heterozygous duplication, 
respectively.  
Real-time PCR assay 
 Gene dosage of different samples was performed 
with relative quantification real-time PCR method. 
Real-time PCR reaction was performed using Luna 
Universal qPCR Master Mix (M3003-NEB) and 
primers used for quantitative analysis of RB1 gene 
were referred to Ahani’s study (RB1-RT-E7, RB1-
RT-E22, and RPPH1, a reference gene with single 
copy) (Ahani et al., 2013). The copy numbers of 
each exon in comparison to reference gene was 
determined according to equation: 
ΔΔCt=CtRPPH1(reference sample)- 
CtRB1exon(reference sample)-[CtRPPH1(unknown 
sample)- CtRB1exon(unknown sample)]. Then the 
relative copy numbers of the gene were calculated 
following ratio equation (2-ΔΔCt). The expected 
values were about 1 for normal coy number, 0.5 for 
heterozygous deletions and 1.5 for heterozygous 
duplications.  
RESULTS AND DISCUSSION 
Identification of RB1 gene deletions/duplications 
by MLPA assay  
 The genomic DNA concentrations from three 
Rb affected children and a healthy child, as a 
reference sample, were ranging from 20 to 37.5 
ng/µl (Table 2). Electrophoresis of total DNA 
product on agarose gel showed clear and bright 
bands (data not shown), indicated that the product 
was not broken and reached purification level for 
the next experiment. As a result, heterozygous 
deletions were found in KVM21 (whole gene) and 
KVM38 (partially from exon 4 to exon 27) while 
KVM22 did not have any abnormal copy number 
compared to reference sample. The DQ values of 
KVM21 (exon 1-27) and KVM38 (exon 4-27) 
ranging from 0.44–0.6 and 0.41–0.67, respectively. 
In KVM21, the signal peaks of exon 1 to 27 were 
all half lower than the control samples (Figure 1A-
B). Similar signal peaks pattern was observed from 
exon 4 to exon 27 of KVM38 (Fig. 1D). For 
KVM22, DQ value of all probes were about 0.8–
1.2 similar to the control samples, indicating there 
were not any large deletion/duplication appear in 
the RB1 gene of this patient. The electropherogram 
of KVM22 was also illustrated the peaks with 
corresponding height to that of control samples 
(Fig. 1C). 
Table 2. Result of total DNA quantification. 
 
Sample Concentration (ng/µl) 
REF 37.5 
KVM21 34.1 
KVM22 22.2 
KVM38 20 
Identification of RB1 gene deletions/duplications 
by real-time PCR assay 
 Real-time PCR is a high throughput technique 
for determining gene copy number by measuring of 
PCR amplicon accumulation in real time. This study 
conducted real-time PCR as an additional method to 
validate the MLPA results. DNA samples of 3 
patients and 1 healthy child above were applied to 
real-time PCR assay using specific primer pairs for 
exon 7 and exon 22 of RB1 gene. The comparative 
analysis results showed that the copy numbers 
(presented as 2-ΔΔCt value) of exon 7 and exon 22 of 
KVM22 sample was equal to those of reference 
sample while the copy numbers of KVM21 and 
KVM38 were less than one-haft when comparing to 
the reference sample (Fig. 2). Those results 
correlated completely with MLPA results. 
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Figure 1. Electrophotogram of MLPA. KVM: patient samples; REF: healthy control sample.	
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 Screening RB1 genetic mutations is a critical 
step in clinical management as well as genetic 
counseling for patient’s family. Previously, gross 
rearrangements of RB1 gene can be detected by 
several techniques such as karyotype, G-banding, 
FISH, QFM-PCR (quantitative fluorescent multiplex 
polymerase chain reaction), MLPA and real-time 
PCR (Houdayer et al., 2004; Lohmann et al., 1992; 
Lohmann et al., 1994; Zielinski et al., 2005). 
However, karyotype and FISH can only recognize 
huge re-combination such as the deletion of a whole 
genome. Real-time PCR has a high accuracy but is 
hard to carry out a high throughput in one single run. 
MPLA and QFM-PCR has an advantage that allows 
reading the whole gene in one reaction. QFM-PCR 
can usually have technical problem, has relatively 
low throughput and low-reproductively, while 
MLPA is easier to carry out because all the 
necessary reagents and probes are commercially 
available. Furthermore, MLPA is technically 
uncomplicated and suitable for processing large 
number of samples with short turnaround time. Some 
research results showed that combining sequencing 
and MLPA had increased the sensitivity of 
diagnosis. Specifically, a research from China 
demonstrated that the rate of mutation detection had 
increased from 78.6% (only Sanger sequencing) to 
92.3% (combined sequencing with MLPA)  (He et 
al., 2014). Research on Malaysian patients had also 
reported that the rate of mutation recognition is 
52.6% (combine sequencing with MLPA), higher 
than that of sequencing only (36.8%) and MLPA 
only (15.8%) (Mohd Khalid et al., 2015). Direct 
sequencing of RB1 exons and intron boundary 
regions combine with detection of large 
deletion/duplication by using MLPA is a standard 
method for identifying germline mutations. In this 
research, we have found 2/3 of children with Rb 
having large deletion on RB1 gene, one had a 
complete loss of one allele and one had a partial 
deletion from exon 4-27 of RB1 gene. These are 
germinal mutations, both of them had tumor 
developed in both eyes. For the KVM22 sample, 
both DNA sequencing and MLPA method could not 
identify any germline mutation in RB1 gene despite 
this child is bilateral. This issue can be explained by 
three hypotheses. First, this patient carries mutations 
on both of the RB1 alleles but it only appeared 
during the development of retina, these are somatic 
mutations and are not inheritable. In this case, RB1 
gene mutations in patient tumor can be continued to 
analyze. Second, this child carries mutations in RB1 
gene but in the somatic form which occurred during 
embryonic development so that not all cells in the 
body were mutated, thus the mutation could not be 
found in peripheral blood sample. In order to 
accurately detect somatic mutation, high sensitivity 
methods are required such as allele specific 
amplification or next generation sequencing (Chen  
et al., 2014). Third, this patient is unlikely to carry 
Figure 2. Real-time PCR results. The copy numbers of the exon 7 and exon 22 from each sample was compared to 
reference gene RPPH1. KVM; patient samples; REF; healthy control sample. 
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any mutation in RB1 gene, as this is reasonable since 
some previous studies have implied that somatic 
mutations in some other genes can also responsible 
for the formation and development of retina tumor 
(Kooi et al., 2016). 
 We have succeeded in approaching analysis of 
Rb patient samples in order to identify 
deletions/duplications in RB1 gene by MLPA 
method. This research has contributed to build up a 
more comprehensive genetic analysis of Rb patients 
in Vietnam. Survivors of hereditary retinoblastoma 
have increased risk of developing other cancers later 
in life. Therefore, the collected results are an 
important source of evidences for clinical 
management and genetic counseling for patient’s 
family as well as prognosis for the occurrence of 
tumors on other organs of RB patients, for instance, 
osteosarcoma and melanoma. 
CONCLUSION 
 We were successful in identifying 2 of 3 Rb 
patients with large heterozygous deletion mutations 
in RB1 gene. The collected results indicated that 
MLPA is a fast, reliable and powerful method to 
assess the deletions/duplications of RB1 gene in 
patients with retinoblastoma. The results of this 
study contribute to the improvement of molecular 
analysis and technique in diagnosis of 
Retinoblastoma in Vietnam. 
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NGHIÊN CỨU ỨNG DỤNG KỸ THUẬT KHUẾCH ĐẠI ĐẦU DÒ ĐA MỒI (MLPA) 
TRONG CHẨN ĐOÁN PHÂN TỬ BỆNH U NGUYÊN BÀO VÕNG MẠC 
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1Viện Nghiên cứu hệ gen, Viện Hàn lâm Khoa học và Công nghệ Việt Nam 
2Học viện Khoa học và Công nghệ, Viện Hàn lâm Khoa học và Công nghệ Việt Nam  
 
TÓM TẮT 
 U nguyên bào võng mạc (Rb) là bệnh mắt ác tính ở trẻ em, thường biểu hiện trước 5 tuổi. Bệnh phát triển 
khi cả 2 alen của gen RB1 trên 13q14.2 bị đột biến. Mục tiêu của nghiên cứu này là đánh giá khả năng sử dụng 
phương pháp MLPA (khuếch đại đầu dò đa mồi) để phát hiện các đột biến mất đoạn/lặp đoạn trên gen RB1 ở 
những bệnh nhi u nguyên bào võng mạc Việt Nam. DNA tổng số được tách chiết từ máu ngoại vi của các bệnh 
nhi và được phân tích bằng phương pháp MLPA. Để kiểm định kết quả phân tích gen của MLPA, số lượng bản 
sao gen RB1 của các mẫu nghiên cứu đã được xác định bằng phương pháp real-time PCR định lượng. Hai đột 
biến mất đoạn lớn được phát hiện trên bệnh nhi KVM21 (mất toàn bộ 1 alen RB1) và KVM38 (mất từ exon 4 
đến exon 27). Kết quả thu được từ MLPA hoàn toàn phù hợp với kết quả kiểm tra bằng real-time PCR. Đây là 
những đột biến gây bệnh và di truyền được, do đó thông tin về những đột biến này rất có ý nghĩa đối với tư vấn 
di truyền và quản lý lâm sàng. Kết quả từ nghiên cứu này cho thấy MLPA là phương pháp nhanh chóng và 
đáng tin cậy trong việc phát hiện những đột biến mất đoạn/lặp đoạn ở bệnh nhi u nguyên bào võng mạc.  
Từ khóa: U nguyên bào võng mạc, đột biến mất đoạn/lặp đoạn, gen RB1, MLPA, tư vấn di truyền 
 
